Page last updated: 2024-11-05

n-hexadecane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Hexadecane, also known as cetane, is a saturated hydrocarbon with the chemical formula C16H34. It is a colorless, odorless, and flammable liquid at room temperature.

n-Hexadecane is found naturally in crude oil and is a major component of diesel fuel. It is also used as a solvent, a heat transfer fluid, and a component of cosmetics and pharmaceuticals.

n-Hexadecane is synthesized from the cracking of long-chain hydrocarbons. It is also produced by the Fischer-Tropsch process, a synthetic process that converts carbon monoxide and hydrogen to hydrocarbons.

n-Hexadecane is a significant component of diesel fuel due to its high cetane number, which measures the ignition quality of diesel fuel. A higher cetane number indicates faster and smoother ignition, leading to less knocking and smoother engine operation.

n-Hexadecane is studied to understand its properties and its impact on the environment. It is also studied to develop new and improved methods for producing and refining diesel fuel.'

n-hexadecane: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hexadecane : A straight-chain alkane with 16 carbon atoms. It is a component of essential oil isolated from long pepper. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11006
CHEMBL ID134994
CHEBI ID45296
MeSH IDM0051408

Synonyms (69)

Synonym
hexadecane
n-hexadecane
n-cetane
544-76-3
cetane
nsc7334
nsc-7334
hsdb 6854
einecs 208-878-9
ccris 5833
brn 1736592
nsc 7334
ai3-06522
CNS ,
inchi=1/c16h34/c1-3-5-7-9-11-13-15-16-14-12-10-8-6-4-2/h3-16h2,1-2h
hexadecane, analytical standard
zetan
CHEBI:45296 ,
ch3-[ch2]14-ch3
cetan
hexadekan
NCGC00164132-01
hexadecane, reagentplus(r), 99%
hexadecane, anhydrous, >=99%
5166841B-BF92-4A7D-8CEF-0B01B374ED0E
CHEMBL134994
QSPL 078
H0066
S0288
QSPL 025
NCGC00164132-02
QSPL 116
LMFA11000577
dtxcid607195
cas-544-76-3
tox21_300485
dtxsid0027195 ,
NCGC00254306-01
A830206
HEXADECANE_RAMANATHANGURUDEEBAN
hexadecan
f8z00shp6q ,
ec 208-878-9
4-01-00-00537 (beilstein handbook reference)
unii-f8z00shp6q
FT-0632360
parafol 16-97
hexadecane [inci]
hexadecane, n-
hexadecane [hsdb]
AKOS025212855
mfcd00008998
STL453674
pentadecane, methyl-
hexadecane, purum, >=98.0% (gc)
hexadecane, >=99%
hexadecane, vetec(tm) reagent grade, 98%
hexadecane, p.a., 99%
hexadecane; cetane; nsc 7334; s 6 (alkane); n-cetane; n-hexadecane
n-hexadecane 10 microg/ml in acetone
Q150843
D97389
AS-56424
hexadecane-1-d 98 atom % d
CS-0152222
SY010655
hexadecane solution
ch3-(ch2)14-ch3
unii: f8z00shp6q

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Addition of 5% hexadecane to the diet of rats increased fecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) from 14 to 39% of an LD50 dose (60 micrograms/kg) during 10 days after dosing."( Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?
Rozman, K, 1984
)
0.27

Bioavailability

The secreted rhamnolipids appeared to be efficient in increasing hexadecane availability for the cells. This was found to favor the bioavailability of n-hexadecanes when it served as the sole carbon source for E. salmoninarum 27BN.

ExcerptReferenceRelevance
"Low pollutant substrate bioavailability limits hydrocarbon biodegradation in soils."( Assessing the role of Pseudomonas aeruginosa surface-active gene expression in hexadecane biodegradation in sand.
Bruce, AK; Holden, PA; LaMontagne, MG; Lindow, SE; Miller, WG, 2002
)
0.31
" Growth of Renibacterium salmoninarum 27BN on n-hexadecane depended on the bioavailability of the substrate and the secreted rhamnolipids appeared to be efficient in increasing hexadecane availability for the cells."( Rhamnolipid biosurfactants produced by Renibacterium salmoninarum 27BN during growth on n-hexadecane.
Christova, N; Jordanov, B; Jordanova, A; Lalchev, Z; Tuleva, B,
)
0.61
" subtilis enhances the bioavailability of hydrophobic liquids."( Chromosomal integration of sfp gene in Bacillus subtilis to enhance bioavailability of hydrophobic liquids.
Kim, HS; Kim, JG; Kim, SB; Lee, YK; Oh, HM; Park, CS; Yoon, BD, 2005
)
0.33
" Model results suggest that partitioning of the phenanthrene into the hexadecane phase limits bioavailability at high NAPL mass."( Influence of a nonaqueous phase liquid (NAPL) on biodegradation of phenanthrene.
Kight, WB; Maier, RM; Maier, WJ; Sandrin, TR, 2006
)
0.33
" Hexadecane increased Phe bioavailability for C(I-AT) bacteria which degraded Phe according to first-order kinetics."( Biodegradation of phenanthrene and analysis of degrading cultures in the presence of a model organo-mineral matrix and of a simulated NAPL phase.
Andreoni, V; Bernasconi, S; Cavalca, L; Colombo, M; Gianfreda, L; Rao, MA, 2008
)
0.35
" This system was used to correlate the absorption rate of metformin through the membrane after release from the dosage form to rate of appearance of metformin in the plasma from the same formulations."( Examination of metformin hydrochloride in a continuous dissolution/HDM system.
Fliszar, KA; Foster, N, 2008
)
0.35
" However, 114 mg/l monoRL suppressed the biodegradation probably because of the reduced bioavailability of hexadecane caused by the micelles."( Effect of monorhamnolipid on the degradation of n-hexadecane by Candida tropicalis and the association with cell surface properties.
Ding, Y; Fu, H; Li, J; Liu, Z; Wang, J; Yuan, X; Zeng, G; Zhong, H; Zhou, M, 2011
)
0.62
" The obtained results suggest that if surfactant-supplementation is to be used as an integral part of a bioremediation process, then possible bioavailability decrease due to entrapment of the contaminant into surfactant micelles should also be taken into consideration, as this phenomenon may have a negative impact on the biodegradation efficiency."( Bioavailability of hydrocarbons to bacterial consortia during Triton X-100 mediated biodegradation in aqueous media.
Chrzanowski, Ł; Lisiecki, P; Marecik, R; Pęziak, D; Piotrowska, A; Szulc, A; Woźniak, M; Ławniczak, Ł, 2013
)
0.39
" The present study focuses on the effect of hydroxy cucurbit[6]uril on the bioavailability of hydrocarbons."( Biodegradation of aliphatic hydrocarbons in the presence of hydroxy cucurbit[6]uril.
Banerjee, M; Chandrasekharan, S; Ganguly, A; Kumar, V; Mutnuri, S; Pasumarthi, R, 2014
)
0.4
"In this study, liquid culture systems containing rhamnolipid-solubilized, separate-phase, and multi-state hexadecane as the carbon source were employed for examining the effect of rhamnolipid solubilization on the bioavailability of hexadecane."( Effect of rhamnolipid solubilization on hexadecane bioavailability: enhancement or reduction?
Cheng, M; Liu, G; Liu, S; Liu, Y; Liu, Z; Wang, Z; Yang, X; Zeng, G; Zhong, H, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" It has been shown also that the bile of HCB dosed animals contained HCB metabolites only whereas fecal excretion consisted primarily of the parent compound."( Intestinal excretion of toxic substances.
Rozman, K, 1985
)
0.27
"The disposition of hexachlorobenzene (HCB) was studied in partially jejunectomized (middle section) or colectomized (excision of cecum and proximal colon) rats after iv or ip dosage (1."( Effect of partial jejunectomy and colectomy on the disposition of hexachlorobenzene in rats treated or not treated with hexadecane.
Rozman, K; Rozman, T; Scheufler, E, 1985
)
0.27
" The first 16 days after dosing were characterized by progressive weight loss which went hand in hand with increasing appetite suppression."( Separation of wasting syndrome and lethality caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Rozman, K, 1984
)
0.27
"The effect of hexadecane on the intestinal excretion of hexachlorobenzene was studied in female Sprague-Dawley rats dosed twice with 14C-hexachlorobenzene at 50 mg kg-1 per os."( Enhanced intestinal excretion of hexachlorobenzene in rats by intraluminal injection of hexadecane.
Greim, H; Rozman, K; Rozman, T, 1983
)
0.27
" In contrast, deposition within dosed skin showed the reverse pattern."( Dermal absorption and distribution of topically dosed jet fuels jet-A, JP-8, and JP-8(100).
Brooks, JD; Budsaba, K; Monteiro-Riviere, NA; Riviere, JE; Smith, CE, 1999
)
0.3
" This system was used to correlate the absorption rate of metformin through the membrane after release from the dosage form to rate of appearance of metformin in the plasma from the same formulations."( Examination of metformin hydrochloride in a continuous dissolution/HDM system.
Fliszar, KA; Foster, N, 2008
)
0.35
" Dose-response experiments were performed to identify major inhibitory interactions in the most common BDS pathway, the 4S pathway."( Exploring the mechanism of biocatalyst inhibition in microbial desulfurization.
Abin-Fuentes, A; Mohamed, Mel-S; Prather, KL; Wang, DI, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
non-polar solventnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain alkaneAny alkane having a chain length of at least 13 carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.08910.000214.376460.0339AID588532
retinoid X nuclear receptor alphaHomo sapiens (human)Potency23.20680.000817.505159.3239AID1159527; AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.48270.000229.305416,493.5996AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency25.11890.023723.228263.5986AID588543
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency52.39220.000627.21521,122.0200AID651741; AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID23737Partition coefficient (logP)2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID13316Solubility in water was determined; values expressed as -log2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (622)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990100 (16.08)18.7374
1990's81 (13.02)18.2507
2000's195 (31.35)29.6817
2010's219 (35.21)24.3611
2020's27 (4.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.24 (24.57)
Research Supply Index6.51 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index92.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.15%)5.53%
Reviews4 (0.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other667 (99.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]